Mental Health Clinics in Tuscaloosa, AL Accepting Medicare
107 Mental Health Clinics found. Showing 101 - 107
 Serenity And Hope Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2703 7th Street, Tuscaloosa, AL 35401 Phone: 205-579-2836 |
Tuscaloosa Treatment Center Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1001 Mimosa Park Rd, Tuscaloosa, AL 35405 Phone: 205-752-5857 Fax: 205-752-6410 |
Jenkins-richardson & Associates Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1105 Southview Ln Ste 103, Tuscaloosa, AL 35405 Phone: 205-799-1274 |
Lifeflow Therapy Services, Llc Marriage & Family Therapist Medicare: Not Enrolled in Medicare Practice Location: 2825 7th St, Tuscaloosa, AL 35401 Phone: 205-706-4737 |
Alabama Neurology & Sleep Medicine Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 100 Rice Mine Road Loop Ste 301, Tuscaloosa, AL 35406 Phone: 205-345-3881 Fax: 205-345-7242 |
Vanessa Goepel, Lpc-s, Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 2804 8th St Ste 102, Tuscaloosa, AL 35401 Phone: 205-523-4660 |
Clarity Counseling Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 2804 8th St, Tuscaloosa, AL 35401 Phone: 205-523-4024 |
News Archive
Yissum scientists invent new design of TeraHertz-ray
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the University, today announced that Professor L.D. Shvartsman and Professor B. Laikhtman, from the Racah Institute of Physics at the Hebrew University of Jerusalem, have invented a novel design of TeraHertz-ray, or T-ray, lasers.
Eribis Pharmaceuticals' cardiovascular therapy program receives new investment from Karolinska Development
Eribis Pharmaceuticals AB - part of the Karolinska Development portfolio - announced today that it has received follow-on financial investment enabling the company to continue its clinical development program. Based on cardio-protective effects, Eribis' candidate drug has the potential to become an important new therapy for treating acute coronary syndrome (ACS) and reperfusion injury (damage to tissue caused when blood supply returns after a period of ischemia), as well as for surgical preconditioning. The new round of investment from Karolinska Development AB will allow Eribis to strengthen the preclinical material.
Study shows that IVIG could prevent brain atrophy, delay onset of Alzheimer's disease
In a Sutter Institute of Medical Research study published this month in the Journal of Neurology, Neurosurgery, and Psychiatry, the blood product intravenous immunoglobulin, or IVIG, was found to reduce brain atrophy and cognitive decline in patients in the early, pre-dementia phase of Alzheimer's disease.
New discoveries on genes implicated in Fanconi anaemia
An international research consortium, which included the participation of the Mutagnesi Group from the UAB, has made outstanding progress in the study of Fanconi anaemia.
› Verified 8 days ago